Barbara Ann Burtness, MD of Yale Cancer Center explains whether or not patients with head and neck cancers should be tested for PD-L1. This was recorded at the 2017 Annual Meeting Annual Meeting in Chicago, IL.
Should H&N patients be routinely tested for PD-L1?
